Calendar of events

April 29 – May 2, 2024 | Boston, MA

Join the ever-growing community of LNP pioneers as they tackle the challenges associated with developing safe, compliant and efficacious LNPs. This starts with the in vitro discovery of LNPs through to the manufacturing processes, with end-to-end synergy fundamental.

Hear from returning industry powerhouses including Pfizer, Moderna and Alnylam alongside new companies to share their insights to this community such as Capstan Therapeutics, AbbVie, Mana Bio, Serina Therapeutics, Karma Biotechnologies and more.

With an expanded content offering a 3-track and 4-day summit format, we continue to be the most comprehensive, premium LNP content available to industry.

April 29 – May 1, 2024 | Amsterdam, Netherlands

Building upon the momentum and progress in the field, such as the announcement of the first British patient to be receiving mRNA-based cancer therapy, the 7th International Neoantigen Summit 2024 returns to Amsterdam to unite the international neoantigen community to overcome neoantigen identification, prediction, and translational challenges that are holding back the full potential of this class of therapies.

Join leading neoantigen trailblazers from the likes of Gritstone Bio, CureVac, Medigene, Geneos Therapeutics & Nykode Therapeutics at the only end-to-end, industry-dedicated neoantigen meeting covering the depth and breadth of the field from mRNA- to DNA- and viral vector-based vaccines as well as novel cell therapies with the true potentials to develop safe, durable and effective off-the-shelf or individualized neoantigen immunotherapeutics and vaccines for cancer patients.

Our expert team will be in attendance so make sure to book ahead of time to speak with Jacob Pacey about the evolving landscape and its promising future!

May 21 – 23, 2024 | Boston, MA

Returning to Boston for its 6th year, the Treg-Directed Therapies Summit stands as the singular industry forum shining a spotlight on the groundbreaking research and clinical advancements in CAR-Treg and IL2 mutein therapies.

As the pioneering and longest-tenured meeting dedicated to optimizing and manipulating Treg-based approaches, this summit invites you to become part of a community at the forefront of innovation. Gain unparalleled insights into the latest developments driving specificity, delve into novel cell product design, and explore the engineering of CAR-Tregs to enhance cell stability and durability.

Don’t miss this unique opportunity to stay ahead in the dynamic landscape of Treg therapies. Join Beacon’s Immune Tolerance Research Analyst, Rachel Hourigan, for a look at the current Treg landscape for autoimmune diseases & recent deals and emerging companies, and contribute to the ongoing dialogue that shapes the future of cutting-edge medical advancements.

May 21 – 23, 2024 | Boston, MA

With a whopping 7 approvals in the last two years, the field is alive with positive clinical readouts and the drive to get more life-changing cell engager therapeutics to patients in indications of huge unmet need.

The timely 6th Cell Engager Therapeutics Summit is back once again to meet the needs of the community, focused on reaching new indications by expanding the target space and focusing our content on novel targets as well as continuing the push to focus on the translational challenges of developing cell engager therapies for solid and liquid tumors.

This is your one-stop shop for all of the must-have content dedicated to all engagers such as T-cell engagers, BiTe’s, gamma delta engagers and NK engages. Join Beacon and our expert Research Analyst, Flavio Lima Bianchi, as he maps out the past, present & future of cell engager therapies. Find out the full Day 2 opening presentation details here.

May 21 – 23, 2024 | Boston, MA

As we enter a new era for cytokine therapies, armed with more cutting-edge technologies than ever before and enhanced translational understandings, the field is re-energizing the cytokine space to bring more life-changing drugs to patients.

Curating learnings from previous experiences, the 5th Cytokine-Based Drug Development Summit returns as the only industry-dedicated cytokine meeting with a disease-agnostic approach.

This year, our Research Analyst, Fatima Hayat, joins the expert speaker faculty to explore the cytokine therapeutics landscape to consider ‘Where Are We Now?’ Access the full presentation details here and join us as we open Day 1!

June 10 – 12, 2024 | Boston, NMA

2024 is shaping up to be a vitally important year for the future of allogeneic cell therapies. With exciting clinical data readouts expected in the coming months and the cell therapy community recognizing autoimmune indications as the promising new cornerstone of research – the tide is shifting for off-the-shelf therapies.

Placing a spotlight on what has been deemed the ‘future of cell therapy’, the 6th Annual Allogeneic Cell Therapies Summit returns to Boston this June as the leading industry-focused meeting dedicated to accelerating the safety, durability, and clinical translation of off-the-shelf therapies to deliver affordable and accessible treatments for patients in critical need.

June 12 – 14, 2024 | Boston, MA

As the first wave of gene therapy programs continues to progress into and through the clinic, attention turns to finding and optimizing the next generation of improved vector candidates. With delivery challenges cited by many as the limiting factor for progress in the field, significant investment continues to pour into improving the safety, efficacy, and predictability of delivery platforms.

In this setting, the 4th Next Generation Gene Therapy Vectors Summit is returning as the only industry-focused event covering the latest advances and innovations in vector development for gene therapies.

Our Senior Research Analyst, Costanza Gorini, will be setting the scene on conference Day 1 with an overview of the current landscape of next-generation gene therapy, so do not miss this ultimate roadmap of the space! Access the full breakdown of the presentation here. Join the world’s experts in Boston to keep your finger on the pulse and support your vector development efforts for 2024 and beyond.

June 18 – 20, 2024 | San Diego, CA

The STING & TLR Targeted Therapies Summit returns as the only industry-led event converging those with crucial insights to fuel the long-awaited success of innate immunity-targeted therapies.

With the field venturing into new approaches to strike that balance between safety and efficacy, from immune agonist conjugates to combination approaches and novel dosing methods, stay ahead of this evolving field with the latest insights to steer you toward success in the clinic.

Presenting ‘An Overview of the Current Development, Clinical Trials & Key Players in the STING & TLR Landscape‘, our Research Analyst, Zer En Peng, joins the expert community and trailblazers to provide actionable insights to unlock the potential of harnessing the innate immune system to meet unmet needs. Access the full presentation details now.

June 25 – 27, 2024 |  Incheon, South Korea